An interventional study of Computer Task Manipulation in Major Depressive Disorder, sponsored by Mclean Hospital. Recruiting at 1 site in United States. Open to female participants aged 14 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-19.
Sponsored by Mclean Hospital · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Depressive Disorder, Major by Mclean Hospital — 7 open to participants now, 7 under way, none of them phase 3. Depressive Disorder, Major · Mclean Hospital.
Among the 32 studies in Depressive Disorder, Major by Mclean Hospital, this one is the 10th largest by planned enrollment of the 22 interventional ones that give a count, is one of 2 that started in 2021, is one of 8 with no phase, and was the 25th registered.
3,051 studies on the registry are indexed under Depressive Disorder, Major; 596 are open to participants now.
Browse Depressive Disorder, Major studies →7 of the 32 studies in Depressive Disorder, Major by Mclean Hospital are open now, in 1 country. Recruiting first, the newest first:
Mclean Hospital · Sites in United States
Ages 18+ · Healthy volunteers
Mclean Hospital · Sites in United States
Ages 18+
Mclean Hospital · Sites in United States
Ages 18+
Mclean Hospital · Sites in United States
Ages 13–15 · Women only · Healthy volunteers
Mclean Hospital · Sites in United States
Ages 18–45 · Healthy volunteers
By country, each count listing its studies:
Of the 419 Depressive Disorder, Major studies recruiting now, 93 (22%) set no upper age limit and 299 (71%) stop at 75 or younger; 55 take children under 18; 100 take healthy volunteers.
This study: 14 Years to 18 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 7 · Phase 2 3 · Phase 3 1 · Phase 4 5
First in 2004; this study’s year is marked. 2 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is close to the median of 80 across 2,535 interventional studies indexed under Depressive Disorder, Major.
Median enrollment 80 across the 22 interventional studies, 112 across the 10 observational. Of the 24 that completed or were terminated, 12 (50%) have results posted.
This tab as a report to print or save as PDF → With an account.
Mclean Hospital is the lead sponsor of 185 studies on the registry; 31 are open to participants now.
Of its 15 completed or terminated interventional studies of FDA-regulated products, 12 (80%) have results posted.
2 of the studies in Depressive Disorder, Major by Mclean Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07785102Mclean HospitalSingle Day of Ultra-accelerated TMS With a Single Dose of NRX-101 | 2026-12-31 |
| NCT05232032Mclean HospitalPharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipulation | 2027-03-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 32 studies in Depressive Disorder, Major by Mclean Hospital, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Lack of perceived control, particularly during stress, has been critically implicated in major depressive disorder (MDD) and anhedonic symptoms, especially among female adolescents; yet the neural underpinnings of perceived control disruptions in MDD remain poorly understood. Using functional magnetic resonance imaging with a novel "value of control task" in conjunction with a prospective design, this study will provide a comprehensive understanding of stress and perceived control related mechanisms in female adolescents with MDD and will examine stress-induced disruptions in perceived control as a predictor of "real world" expressions of maladaptive coping and anhedonia.
Participants in this research will include 40 female adolescents, aged 14-18, with Major Depressive Disorder (MDD) and 40 healthy adolescents from the greater Boston area by Dr. Emily Belleau, at McLean Hospital's Center for Depression, Anxiety and Stress Research.
The study will include four sessions:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Inclusion Criteria: All Participants
Inclusion Criteria: MDD Sample
Inclusion Criteria: Healthy Control (HC) Sample
Exclusion Criteria:
Exclusion Criteria: All Participants
Additional Exclusion Criteria: Major Depressive Disorder (MDD) Sample
1. Major depressive disorder diagnosis secondary to another disorder (selected comorbid anxiety disorders such as generalized anxiety disorder, specific phobia, and social anxiety disorders are allowed if they are secondary to MDD)
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will complete computer tasks while undergoing an fMRI brain scan
Behavioral: Computer Task Manipulation
Participants will complete computer tasks.
Blood-Oxygen-Level-Dependent Imaging (BOLD) activation of the ventral striatum and ventral medial prefrontal cortex
BOLD activation of frontostriatal regions in response to computer tasks performed during the fMRI Brian scan
Time frame: 1.5 hour long scan during session 2
Cortisol Rating
Saliva rating to be collected throughout the fMRI brain scan
Time frame: collected as part of 1.5 hour long scan during session 2
Mood Rating
Self-reported mood rating to be collected throughout the fMRI brain scan
Time frame: collected as part of 1.5 hour long scan during session 2
Stress Reactivity Score
Stress Reactivity Survey Item collected via smart-phone delivered ecological momentary assessment
Time frame: Longitudinal, three time points (baseline, 3-month follow-up, 6-month follow-up)
Stress Reactive Rumination Score
Stress Reactive Rumination Scale collected via smart-phone delivered ecological momentary assessment
Time frame: Longitudinal, three time points (baseline, 3-month follow-up, 6-month follow-up)
Positive Affect Score
Positive Affect Survey Items collected via smart-phone delivered ecological momentary assessment
Time frame: Longitudinal, three time points (baseline, 3-month follow-up, 6-month follow-up)
Plan to share: No
No publications or documents are linked to this record.
Started Apr 2021 (actual). Primary completion is estimated for Oct 2026, 66 months after the start.
Of 654 non-industry interventional studies with no phase under Depressive Disorder, Major, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 55. This study's planned 66 months is above that.
Counting every sponsor, half of 694 studies reached it within 33 months; a quarter within 17 and three quarters within 55.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.